The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) a...
Saved in:
| Published in | PloS one Vol. 9; no. 12; p. e114720 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
08.12.2014
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0114720 |
Cover
| Abstract | Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world.
The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'.
A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year.
The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. |
|---|---|
| AbstractList | Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world. The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'. A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrolment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. Background Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund (‘Siemens-Betriebskrankenkasse’, SBK) initiated the prevention programme ‘KardioPro’ including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of ‘KardioPro’ as it is implemented in the real world. Methods The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint ‘all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)’, ‘all-cause mortality (2)’ and ‘non-fatal acute MI and ischemic stroke (3)’. Results A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. ‘KardioPro’ enrolment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0–32.7%) (1), 41.7% (95% CI 30.2–51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811–1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. Conclusion The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world.The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'.A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year.The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. Background Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world. Methods The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'. Results A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrolment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. Conclusion The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world. The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'. A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world.BACKGROUNDCardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world.The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'.METHODSThe study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'.A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year.RESULTSA total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year.The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events.CONCLUSIONThe prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events. |
| Audience | Academic |
| Author | Leidl, Reiner Holle, Rolf Stollenwerk, Björn Silber, Sigmund Witt, Sabine Becker, Christian Block, Michael Brachmann, Johannes |
| AuthorAffiliation | 3 Klinik Augustinum München, Munich, Germany 5 Herzzentrum an der Isar, Munich, Germany 1 Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management, Neuherberg, Germany Universität Bochum, Germany 4 Klinikum Coburg, Coburg, Germany 2 Ludwig-Maximilians-Universität, Munich Center of Health Sciences, Munich, Germany |
| AuthorAffiliation_xml | – name: 1 Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management, Neuherberg, Germany – name: 3 Klinik Augustinum München, Munich, Germany – name: 2 Ludwig-Maximilians-Universität, Munich Center of Health Sciences, Munich, Germany – name: 4 Klinikum Coburg, Coburg, Germany – name: 5 Herzzentrum an der Isar, Munich, Germany – name: Universität Bochum, Germany |
| Author_xml | – sequence: 1 givenname: Sabine surname: Witt fullname: Witt, Sabine – sequence: 2 givenname: Reiner surname: Leidl fullname: Leidl, Reiner – sequence: 3 givenname: Christian surname: Becker fullname: Becker, Christian – sequence: 4 givenname: Rolf surname: Holle fullname: Holle, Rolf – sequence: 5 givenname: Michael surname: Block fullname: Block, Michael – sequence: 6 givenname: Johannes surname: Brachmann fullname: Brachmann, Johannes – sequence: 7 givenname: Sigmund surname: Silber fullname: Silber, Sigmund – sequence: 8 givenname: Björn surname: Stollenwerk fullname: Stollenwerk, Björn |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25486421$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk81uEzEQx1eoiLaBN0BgqRKCQ4LX6_3qASnqFxGVitrC1Zr1jhOX3XWxvRW59THgyqP1SXDSFDVVhZAPtsa_-Y_nL892tNGZDqPoZUxHcZLH7y9MbztoRpchPKJxzHNGn0RbcZmwYcZosnHvvBltO3dBaZoUWfYs2mQpLzLO4q3o9_kMyYFSKL2-wg6dI0YRH4J7YGttrsDJvgFL9rVDcEg-Wwyc16YLRzO10LZIbq5_flriIXRz_YtMOu01eKxJNSdAjtC20JEzLb8tKxz2Xb1LxuRctzj0ZniwUCTj0M3c6eUDTk3vdYdkHzw8j54qaBy-WO2D6Mvhwfnex-HxydFkb3w8lFnJ_JBnKPO0RMl5neV1UqWqTlilWMKTrFAZ1HmNRVrKqqJVVVBIWZWlDHil4pjlKhlEr291LxvjxMpeJ-Is4TxPimDeIJrcErWBC3FpdQt2LgxosQwYOxVgvZYNClAIeUELGqpzLutCpqxEBbkqWAUlBq0Pq2p91WItgwMWmjXR9ZtOz8TUXAnO0pJnSRB4uxKw5nuPzotWO4lNAx2afvnulNKizHhAdx6gj3e3oqYQGtCdMqGuXIiKMY-LAOZLrdEjVFg1tlqGv6h0iK8lvFtLCIzHH34KvXNicnb6_-zJ13X2zT12htD4mTNNv_iabh18dd_pvxbfDUEAdm8BaY1zFpWQ2sNCJ7SmGxFTsZi4O9PEYuLEauJCMn-QfKf_z7Q_ouYy8A |
| CitedBy_id | crossref_primary_10_1016_j_healthpol_2015_01_012 crossref_primary_10_1007_s11886_023_01899_2 |
| Cites_doi | 10.1002/pds.3386 10.1177/0272989X09331810 10.1016/j.jtcvs.2007.07.021 10.2147/VHRM.S16340 10.1136/bmj.323.7319.957 10.1007/978-1-4757-2555-1 10.1503/cmaj.090917 10.1093/aje/kwr301 10.1371/journal.pone.0005195 10.1001/archinternmed.2009.516 10.1161/hc0302.102575 10.1016/j.healthpol.2009.12.015 10.1016/j.jacc.2009.09.081 10.1093/epirev/mxg002 10.1016/j.ejvs.2012.08.010 10.1097/HJR.0b013e3283383f30 10.1002/sim.3150 10.1177/1062860610362259 10.1093/eurheartj/ehs092 10.1093/aje/kwq171 10.1007/s00392-009-0027-z 10.1016/j.ahj.2012.01.027 10.1007/s11883-011-0195-y 10.1007/s12160-010-9206-4 10.1159/000312008 10.1186/1472-6963-8-60 10.1002/14651858.CD001561.pub3 10.1002/pds.1062 10.1002/0471445428 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2014 Public Library of Science 2014 Witt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Witt et al 2014 Witt et al |
| Copyright_xml | – notice: COPYRIGHT 2014 Public Library of Science – notice: 2014 Witt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Witt et al 2014 Witt et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0114720 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection (ProQuest) ProQuest Central (New) Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database ProQuest Nursing and Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection (ProQuest) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection (ProQuest) Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Effectiveness of ‘KardioPro |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1634473805 oai_doaj_org_article_afea7808034344cd8c529efa7f82ba9e PMC4259463 3520220991 A418634764 25486421 10_1371_journal_pone_0114720 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
| GeographicLocations | New York United States--US Germany |
| GeographicLocations_xml | – name: New York – name: United States--US – name: Germany |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF IPNFZ NPM PV9 RIG RZL PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c692t-46ec759ec44d67d3b5fd32bf234368f6ad7de859cbb0bb80a52b652a4bf1127f3 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Fri Nov 26 17:13:40 EST 2021 Wed Aug 27 01:28:10 EDT 2025 Thu Aug 21 17:51:38 EDT 2025 Mon Sep 08 07:17:58 EDT 2025 Fri Jul 25 09:19:48 EDT 2025 Tue Jun 17 21:15:02 EDT 2025 Tue Jun 10 20:19:03 EDT 2025 Fri Jun 27 04:52:07 EDT 2025 Fri Jun 27 03:44:54 EDT 2025 Thu May 22 21:22:19 EDT 2025 Thu Apr 03 07:00:38 EDT 2025 Tue Jul 01 01:49:15 EDT 2025 Thu Apr 24 22:56:10 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-46ec759ec44d67d3b5fd32bf234368f6ad7de859cbb0bb80a52b652a4bf1127f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 Conceived and designed the experiments: BS RH RL SW. Analyzed the data: SW CB. Wrote the paper: SW BS. Reading and improving the paper: RL CB RH MB JB SS. Interpretation and discussion of the results: SW BS RL RH CB MB JB SS. Design of ‘KardioPro': MB JB SS. Competing Interests: Financial support for this study was provided by SBK and by Helmholtz Zentrum München, German Research Center for Environmental Health. The data have been provided by SBK. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials, besides the restrictions specified in the methods section. However, SBK had the opportunity to comment upon the paper. MB, JB and SS provided services for ‘KardioPro’ as part of their reimbursed outpatient care. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0114720 |
| PMID | 25486421 |
| PQID | 1634473805 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1634473805 doaj_primary_oai_doaj_org_article_afea7808034344cd8c529efa7f82ba9e pubmedcentral_primary_oai_pubmedcentral_nih_gov_4259463 proquest_miscellaneous_1635008964 proquest_journals_1634473805 gale_infotracmisc_A418634764 gale_infotracacademiconefile_A418634764 gale_incontextgauss_ISR_A418634764 gale_incontextgauss_IOV_A418634764 gale_healthsolutions_A418634764 pubmed_primary_25486421 crossref_citationtrail_10_1371_journal_pone_0114720 crossref_primary_10_1371_journal_pone_0114720 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-12-08 |
| PublicationDateYYYYMMDD | 2014-12-08 |
| PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-08 day: 08 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2014 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | FA McAlister (ref14) 2001; 323 G Assmann (ref20) 2002; 105 AU Shenoy (ref11) 2012; 44 CD Mack (ref23) 2013; 22 SL Sheridan (ref8) 2010; 170 ref31 V Snow (ref9) 2010; 25 ref32 I Schubert (ref37) 2013; 110 M Pennant (ref13) 2010; 172 ref1 ref17 FA McAlister (ref18) 2009; 181 SL Sheridan (ref12) 2008; 8 P Cummings (ref30) 2003; 25 MK Eriksson (ref6) 2009; 4 JD Seeger (ref24) 2005; 14 PC Austin (ref22) 2008; 27 MG Kirby (ref35) 2010; 115 J Perk (ref15) 2012; 33 ref26 ER McGrath (ref33) 2012; 163 J Heidrich (ref5) 2005; 12 ref25 PK Shah (ref3) 2010; 56 E Falk (ref2) 2011; 13 LS Maier (ref4) 2009; 98 PC Austin (ref21) 2007; 134 ref28 ref27 K Kotseva (ref19) 2010; 17 ref29 G Danaei (ref36) 2012; 175 L Angermayr (ref16) 2010; 40 EB Colkesen (ref10) 2011; 7 B Stollenwerk (ref7) 2009; 29 S Stock (ref34) 2010; 96 19468779 - Clin Res Cardiol. 2009 Jul;98(7):413-9 22555213 - Eur Heart J. 2012 Jul;33(13):1635-701 12923989 - Epidemiol Rev. 2003;25:43-50 20395680 - Cardiology. 2010;115(4):294-6 20142567 - Arch Intern Med. 2010 Feb 8;170(3):230-9 22995752 - Eur J Vasc Endovasc Surg. 2012 Nov;44(5):505-13 23296544 - Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):810-8 20106543 - Health Policy. 2010 Jun;96(1):51-6 20652464 - Ann Behav Med. 2010 Aug;40(1):49-64 11679383 - BMJ. 2001 Oct 27;323(7319):957-62 22223710 - Am J Epidemiol. 2012 Feb 15;175(4):250-62 11804985 - Circulation. 2002 Jan 22;105(3):310-5 19933787 - CMAJ. 2009 Dec 8;181(12):897-904 20577089 - Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40 20460560 - Am J Med Qual. 2010 Jul-Aug;25(4):261-7 21811799 - Curr Atheroscler Rep. 2011 Oct;13(5):345-52 21249647 - Cochrane Database Syst Rev. 2011;(1):CD001561 17976439 - J Thorac Cardiovasc Surg. 2007 Nov;134(5):1128-35 18038446 - Stat Med. 2008 May 30;27(12):2037-49 23413387 - Dtsch Arztebl Int. 2013 Jan;110(4):45-51 20667932 - Am J Epidemiol. 2010 Sep 1;172(5):501-16 19773581 - Med Decis Making. 2009 Sep-Oct;29(5):619-33 15651087 - Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):465-76 21415919 - Vasc Health Risk Manag. 2011;7:67-74 20620724 - J Am Coll Cardiol. 2010 Jul 6;56(2):98-105 16319540 - Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):521-9 18366711 - BMC Health Serv Res. 2008;8:60 22520539 - Am Heart J. 2012 Apr;163(4):714-9 19365563 - PLoS One. 2009;4(4):e5195 |
| References_xml | – volume: 22 start-page: 810 year: 2013 ident: ref23 article-title: Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3386 – ident: ref1 – volume: 12 start-page: 521 year: 2005 ident: ref5 article-title: Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany publication-title: Eur J Cardiovasc Prev Rehabil – volume: 29 start-page: 619 year: 2009 ident: ref7 article-title: The German Coronary Artery Disease Risk Screening Model: development, validation, and application of a decision-analytic model for coronary artery disease prevention with statins publication-title: Med Decis Making doi: 10.1177/0272989X09331810 – volume: 110 start-page: 45 year: 2013 ident: ref37 article-title: Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data publication-title: Dtsch Arztebl Int – volume: 134 start-page: 1128 year: 2007 ident: ref21 article-title: Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement publication-title: J Thoracic Cardiovasc Surg doi: 10.1016/j.jtcvs.2007.07.021 – volume: 7 start-page: 67 year: 2011 ident: ref10 article-title: Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study publication-title: Vasc Health Risk Manag doi: 10.2147/VHRM.S16340 – volume: 323 start-page: 957 year: 2001 ident: ref14 article-title: Randomised trials of secondary prevention programmes in coronary heart disease: systematic review publication-title: BMJ doi: 10.1136/bmj.323.7319.957 – ident: ref29 doi: 10.1007/978-1-4757-2555-1 – volume: 181 start-page: 897 year: 2009 ident: ref18 article-title: The Enhancing Secondary Prevention in Coronary Artery Disease trial publication-title: Can Med Assoc J doi: 10.1503/cmaj.090917 – ident: ref25 – volume: 175 start-page: 250 year: 2012 ident: ref36 article-title: Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins publication-title: Am J Epidemiol doi: 10.1093/aje/kwr301 – volume: 4 start-page: e5195 year: 2009 ident: ref6 article-title: A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Bjorknas study publication-title: PLoS One doi: 10.1371/journal.pone.0005195 – ident: ref27 – ident: ref32 – volume: 170 start-page: 230 year: 2010 ident: ref8 article-title: The effect of giving global coronary risk information to adults: a systematic review publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.516 – volume: 105 start-page: 310 year: 2002 ident: ref20 article-title: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study publication-title: Circulation doi: 10.1161/hc0302.102575 – volume: 96 start-page: 51 year: 2010 ident: ref34 article-title: Financial incentives in the German Statutory Health Insurance: new findings, new questions publication-title: Health Policy doi: 10.1016/j.healthpol.2009.12.015 – volume: 56 start-page: 98 year: 2010 ident: ref3 article-title: Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.09.081 – volume: 25 start-page: 43 year: 2003 ident: ref30 article-title: Matched cohort methods for injury research publication-title: Epidemiol Rev doi: 10.1093/epirev/mxg002 – volume: 44 start-page: 505 year: 2012 ident: ref11 article-title: Limited economic evidence of carotid artery stenosis diagnosis and treatment: a systematic review publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/j.ejvs.2012.08.010 – volume: 17 start-page: 530 year: 2010 ident: ref19 article-title: EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries publication-title: Eur J Cardiovasc Prev Rehabil doi: 10.1097/HJR.0b013e3283383f30 – volume: 27 start-page: 2037 year: 2008 ident: ref22 article-title: A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003 publication-title: Stat Med doi: 10.1002/sim.3150 – volume: 25 start-page: 261 year: 2010 ident: ref9 article-title: Closing the gap-cardiovascular risk and primary prevention: results from the American College of Physicians quality improvement program publication-title: Am J Med Qual doi: 10.1177/1062860610362259 – volume: 33 start-page: 1635 year: 2012 ident: ref15 article-title: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs092 – ident: ref28 – volume: 172 start-page: 501 year: 2010 ident: ref13 article-title: Community programs for the prevention of cardiovascular disease: a systematic review publication-title: Am J Epidemiol doi: 10.1093/aje/kwq171 – volume: 98 start-page: 413 year: 2009 ident: ref4 article-title: Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009 publication-title: Clin Res Cardiol doi: 10.1007/s00392-009-0027-z – ident: ref26 – volume: 163 start-page: 714 year: 2012 ident: ref33 article-title: Preventing cardiovascular disease in primary care: role of a national risk factor management program publication-title: Am Heart J doi: 10.1016/j.ahj.2012.01.027 – volume: 13 start-page: 345 year: 2011 ident: ref2 article-title: The SHAPE guideline: ahead of its time or just in time publication-title: Curr Atheroscler Rep doi: 10.1007/s11883-011-0195-y – volume: 40 start-page: 49 year: 2010 ident: ref16 article-title: Multifactorial lifestyle interventions in the primary and secondary prevention of cardiovascular disease and type 2 diabetes mellitus—a systematic review of randomized controlled trials publication-title: Ann Behav Med doi: 10.1007/s12160-010-9206-4 – volume: 115 start-page: 294 year: 2010 ident: ref35 article-title: Cardiovascular disease prevention, screening and early detection in Turkey publication-title: Cardiology doi: 10.1159/000312008 – volume: 8 start-page: 60 year: 2008 ident: ref12 article-title: Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-8-60 – ident: ref17 doi: 10.1002/14651858.CD001561.pub3 – volume: 14 start-page: 465 year: 2005 ident: ref24 article-title: An application of propensity score matching using claims data publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1062 – ident: ref31 doi: 10.1002/0471445428 – reference: 20460560 - Am J Med Qual. 2010 Jul-Aug;25(4):261-7 – reference: 22995752 - Eur J Vasc Endovasc Surg. 2012 Nov;44(5):505-13 – reference: 22555213 - Eur Heart J. 2012 Jul;33(13):1635-701 – reference: 22520539 - Am Heart J. 2012 Apr;163(4):714-9 – reference: 19468779 - Clin Res Cardiol. 2009 Jul;98(7):413-9 – reference: 21811799 - Curr Atheroscler Rep. 2011 Oct;13(5):345-52 – reference: 20395680 - Cardiology. 2010;115(4):294-6 – reference: 20577089 - Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40 – reference: 21415919 - Vasc Health Risk Manag. 2011;7:67-74 – reference: 16319540 - Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):521-9 – reference: 11804985 - Circulation. 2002 Jan 22;105(3):310-5 – reference: 20667932 - Am J Epidemiol. 2010 Sep 1;172(5):501-16 – reference: 22223710 - Am J Epidemiol. 2012 Feb 15;175(4):250-62 – reference: 20620724 - J Am Coll Cardiol. 2010 Jul 6;56(2):98-105 – reference: 15651087 - Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):465-76 – reference: 19933787 - CMAJ. 2009 Dec 8;181(12):897-904 – reference: 18366711 - BMC Health Serv Res. 2008;8:60 – reference: 23296544 - Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):810-8 – reference: 19773581 - Med Decis Making. 2009 Sep-Oct;29(5):619-33 – reference: 23413387 - Dtsch Arztebl Int. 2013 Jan;110(4):45-51 – reference: 11679383 - BMJ. 2001 Oct 27;323(7319):957-62 – reference: 17976439 - J Thorac Cardiovasc Surg. 2007 Nov;134(5):1128-35 – reference: 18038446 - Stat Med. 2008 May 30;27(12):2037-49 – reference: 20142567 - Arch Intern Med. 2010 Feb 8;170(3):230-9 – reference: 20106543 - Health Policy. 2010 Jun;96(1):51-6 – reference: 21249647 - Cochrane Database Syst Rev. 2011;(1):CD001561 – reference: 20652464 - Ann Behav Med. 2010 Aug;40(1):49-64 – reference: 12923989 - Epidemiol Rev. 2003;25:43-50 – reference: 19365563 - PLoS One. 2009;4(4):e5195 |
| SSID | ssj0053866 |
| Score | 2.151575 |
| Snippet | Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund... Background Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness... Background Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e114720 |
| SubjectTerms | Cardiology Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Case-Control Studies Cerebral infarction Confidence intervals Data Interpretation, Statistical Data processing Disease prevention Environmental health Ethics Failure analysis Female Hazards Health care policy Health economics Health Personnel - standards Heart attack Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Infarction Insurance, Health Ischemia Male Medical diagnosis Medicine and Health Sciences Middle Aged Morbidity Mortality Myocardial infarction Prevention Primary Prevention Prognosis Program Evaluation Propensity Score Reduction Regression analysis Retrospective Studies Risk Factors Risk reduction Statistical analysis Stroke Studies Survival analysis Survival Rate Systematic review Time Factors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQ5dWlBQxCWjikTWLHjrkVRCkgHgKKeov8hIqSrPZx4M_wW5lxvNEGVSoHrvEX72ZeHicznwl5HBlDeAD_9sZl3DB80RRcVlnw8mDBNw2-h3z3Xhyf8Den1enGUV9YE9bTA_eCO9DBa4nkh4wzzrGTvSqVD1qGujRaeYy-ucrXm6k-BoMXC5Ea5ZgsDpJe9mdd6_dxCyDxfO-NhSjy9Q9ReWt23i0uSjn_rpzcWIqOrpNrKYekh_1_3yZXfHuDbCcvXdAniUr66U3yG6yA9iUbKarRLlDI-agd1aHS9J2GzhKjU9fSVLn109Pp2wj-OO-m9AyLjSA_ddT8opq-wsDeUlD1jzg7LJPuGVzHI-uzZZfF2ahOzCf44_MOTL31FEtTb5GTo5dfXhxn6USGzApVLjMuvJWV8pZzJ6RjpgqOlSaUDInsg9BOOl9XyhqTG1PnuiqNqErNTYC8TgZ2m2y1oIMdQrVBQlJnkZ-NW--UKL0qSlMUWqhC1RPC1uppbKIrx1Mzzpv4DU7CtqWXdoNKbZJSJyQb7pr1dB2X4J-j5gcskm3HC2CCTTLB5jITnJAHaDdN37k6hIzmkBe1YFwKPiGPIgIJN1qs6PmmV4tF8_rD138Aff40Ak0TKHQgDqtTFwU8ExJ5jZB7IySEDTsa3kErX0tl0UBizrlkdV7BnWvLv3j44TCMk2KVXuu7VcRUkFMqnP1O7yiDZEvYGmNT9YTIkQuNRD8eac--R75zWFYUF-zu_9DVLrkKKW-k6szrPbK1nK_8PUgrl-Z-jCB_ADKnemg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central (New) dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV5dKGAQEnBIu0kcJ0FCaNvu0oIoqKVVb5GfpaIkS3f3wK0_A678tP4SZhwnNKgCblE8cRLPw2N75htCnjjEEGZBv43UAZMxbjRZHSQKtNwq0E2J-5DvdvjWPntzmBwukJ0mFwbDKhub6Ay1rhTuka-B38BYGmeD5NXka4BVo_B0tSmhIXxpBf3SQYxdIYtgkpNBjyyuj3Y-7Da2GbSbc59AF6fhmufX6qQqzSouDVKs-31hgnI4_q217k1OqullruifEZUXpqjxdXLN-5Z0WAvDElkw5Q2y5LV3Sp95iOnnN8lPkA5aAxd7a0crS8EXpBud-FS6WZ_f0AbpqSrh0kV0fTH0_Oz7W0cOt87PftBtDEQC31VT-Y0K-hqNfkn3jtVn94bxvNQv6JBi1kkwq4IR9kgbVBT8AAxPAq-XboqZuEX2x6OPG1uBr9YQKJ5Hs4Bxo9IkN4oxzVMdy8TqOJI2ihHk3nKhU22yJFdSDqTMBiKJJE8iwaQFny-18W3SK4EPy4QKiWClWiF2G1NG5zwyeRjJMBQ8D_OsT-KGRYXyUOZYUeOkcOdzKSxp6hEvkLGFZ2yfBO1TkxrK4x_068j9lhaBuN2N6vSo8HpdCGtEitic8JeMIdBCEuXGitRmkRS56ZOHKDtFndXampNiyMIMJDrlrE8eOwoE4ygx2udIzKfTYvv9wX8Q7e12iJ56IlvBcCjhMyzgnxDkq0O50qEEk6I6zcso6c2oTIvfygdPNtJ_efOjthk7xQi-0lRzR5OAv5lj73dqZWlHNoJlMyZc90naUaPO0HdbyuNPDgsdppyc8fju3z_rHrkKjq4D6BxkK6Q3O52b--BMzuQDbyF-ARvaeXI priority: 102 providerName: ProQuest |
| Title | The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25486421 https://www.proquest.com/docview/1634473805 https://www.proquest.com/docview/1635008964 https://pubmed.ncbi.nlm.nih.gov/PMC4259463 https://doaj.org/article/afea7808034344cd8c529efa7f82ba9e http://dx.doi.org/10.1371/journal.pone.0114720 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLdGd-GCGF8rjGIQUuGQqkkcO0FCaJvWDRBjGhT1FtmOPSZKUvohsX-Gv5X3HDciqAgOXHKInx3lffnZfv49Qp46xBBmwb6NKgKmYtxoskWQaLByq8E2Fe5DvjvlJ2P2ZpJMtsi6Zqtn4GLj0g7rSY3n08H3b1evwOBfuqoNIlx3Gsyq0gwwwBcRLOK33YkRJvOx5lwBrJtzf4HuTz1bE5TD8W-8dWc2rRabQtHfMyp_maJGN8kNH1vS_VoZdsiWKW-RHW-9C_rMQ0w_v01-gHbQOpXDeztaWQqxINWt_FTqz2_ozCM9VSX1GV1fDe2_dcRn86pPLzEJCeLWgqorKukxOvySggp8caPD9Fm8gPdYyj5YVoEbjUqPiIIfn1dgAqWhmLJ6h4xHRx8PTwJfqSHQPIuWAeNGiyQzmrGCiyJWiS3iSNkoRoB7y2UhCpMmmVZqqFQ6lEmkeBJJpizEe8LGd0mnBBnsEioVApUWGnHbmDZFxiOThZEKQ8mzMEu7JF6LJ9cexhyraUxzdzYnYDlTcztHoeZeqF0SNL1mNYzHX-gPUPINLYJwuxfV_CL3Np1La6RAXE74S8YQZCGJMmOlsGmkZGa65BHqTV7faG1cSb7PwpTHTHDWJU8cBQJxlJjpcyFXi0X--v2nfyD6cN4i6nsiWwE7tPS3K-CfEOCrRbnXogR3olvNu6jla64scgjYGRNxOkyg51rzNzc_bppxUMzeK021cjQJxJoZjn6vNpSGsxEsmfGydZeIlgm1WN9uKS8_Oxx0mG4yxuP7_0NWD8h1CIUdhOcw3SOd5XxlHkK4uVQ9ck1MBDzTwxCfo-Me2T44Oj0777kNnJ7zMD8Bt0GJYg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXRHk1UOiCQMDBbWKvX0gVSpuUhj5AfaDezD5LRbFDkwj11p8BV34IP6a_hJn1OtSoAi69Rd7xxt557nrmG0KeWMQQZkC_tVAeEwEeNBnlhRK03EjQTYHnkJtb0doee7Mf7k-Rn1UtDKZVVjbRGmpVSDwjX4S4gbE4SFrhq8EXD7tG4dfVqoUGd60V1JKFGHOFHev65Cts4YZL_S7w-6nvr_Z2V9Y812XAk1HqjzwWaRmHqZaMqShWgQiNCnxh_ADB2U3EVax0EqZSiJYQSYuHvohCnzNhIFaJTQDzXiHTDA9QGmR6ubf1brvyBWBNosgV7AVxe9HJx8KgyPUCbkVi7DN-ziHavgET79AYHBXDi0LfPzM4z7nE1RvkuotlaacUvhkypfObZMZZiyF97iCtX9wiP0AaaQmU7KwrLQyF2JOu1PJhabf8XkQrZKkih582g-yzpmen39YtOVw6O_1O-5j4BLGyouKEcvoanUxOdw7lJ_sPq-NcvaQdilUu3qjwejgjrVBY8AEwHQqibNrlI36b7F0K3-6QRg58mCWUCwRHVRKx4pjUKo18nbZ90W7zKG2nSZMEFYsy6aDTsYPHUWa_B8awhSpXPEPGZo6xTeJN7hqU0CH_oF9G7k9oEfjbXiiODzJnRzJuNI8RCxTekjEEdgj9VBsem8QXPNVNMo-yk5VVtBPzlXVYOwENiiPWJI8tBYJ_5JhddMDHw2HWf_v-P4h2tmtEzxyRKWA5JHcVHfBOCCpWo5yrUYIJk7XhWZT0alWG2W9lhzsr6b94-NFkGCfFjMFcF2NLE0J8m-Lsd0tlmaysD9t0LPBukrimRrWlr4_khx8t9jq4uJRFwb2_P9Y8ubq2u7mRbfS31u-TaxBkW3DQVjJHGqPjsX4AgexIPHTWgpIPl22gfgExCbdN |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VVkJcEOWvgUIXBAIObhJ77bWRKtQ2CQ2FULUU9Wb2t1QUOzSJUG99DLjyODxGn4QZex1qVAGX3iLveGPv_O565htCHhWIIcyCfhupPSYDPGiy2gsVaLlVoJsSzyHfDKKNXfZqL9ybIT-rWhhMq6xsYmGoda7wjLwJcQNjPIhbYdO6tIitTu_F8IuHHaTwS2vVTkO4Ngt6pYAbc0Uem-b4K2znRiv9DvD-se_3uu_WNzzXccBTUeKPPRYZxcPEKMZ0xHUgQ6sDX1o_QKB2GwnNtYnDREnZkjJuidCXUegLJi3ELdwGMO8lMsfB68NGcG6tO9jarvwCWJYocsV7AW83nawsD_PMLOO2hGPP8TPOseghMPUUs8PDfHReGPxnNucZ99i7Rq66uJauloI4T2ZMdp3MO8sxok8dvPWzG-QHSCYtQZOdpaW5pRCH0vVabiztlN-OaIUylWfws8gm-2zo6cm3zYIcLp2efKd9TIKCuFlTeUwFfYkOJ6M7B-pT8Q-9Saaf01WKFS_eOPe6OCOtEFnwATA1CiJu2hFjcZPsXgjfbpHZDPiwQKiQCJSqFeLGMWV0Evkmafuy3RZR0k7iBgkqFqXKwahjN4_DtPg2yGE7Va54ioxNHWMbxJveNSxhRP5Bv4bcn9IiCHhxIT_aT51NSYU1giMuKLwlYwjyEPqJsYLb2JciMQ2yhLKTlhW1U1OWrrJ2DNrEI9YgDwsKBALJUKX2xWQ0Svtv3_8H0c52jeiJI7I5LIcSrroD3gkBxmqUizVKMGeqNryAkl6tyij9rfhwZyX95w8_mA7jpJg9mJl8UtCEEOsmOPvtUlmmK-vDlh2LvRuE19SotvT1kezgY4HDDu4uYVFw5--PtUQug6FKX_cHm3fJFYi3C5zQVrxIZsdHE3MPYtqxvO-MBSUfLto-_QLgCLuR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effectiveness+of+the+cardiovascular+disease+prevention+programme+%27KardioPro%27+initiated+by+a+German+sickness+fund%3A+a+time-to-event+analysis+of+routine+data&rft.jtitle=PloS+one&rft.au=Sabine+Witt&rft.au=Reiner+Leidl&rft.au=Christian+Becker&rft.au=Rolf+Holle&rft.date=2014-12-08&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=9&rft.issue=12&rft.spage=e114720&rft_id=info:doi/10.1371%2Fjournal.pone.0114720&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_afea7808034344cd8c529efa7f82ba9e |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |